Health

Private cancer clinic claims ministers have IGNORED offer to help tackle backlog

Professor Sikora told MailOnline he is 'very disappointed' that the UK's health bosses have not been more responsive to his offer to provide cancer checks and treatments on a not-for-profit basis

Professor Sikora advised MailOnline he’s ‘very upset’ that the UK’s well being bosses have not been extra responsive to his offer to present cancer checks and coverings on a not-for-profit foundation

Ministers and NHS leaders have ‘ignored’ an offer from a personal clinic to help struggle Sajid Javid’s warfare on cancer, it has been claimed. 

Professor Karol Sikora, founding father of Rutherford Health, wrote to officers in December, providing additional cancer checks and remedy to sufferers in England and Wales.

But 4 months later, after allegedly being bounced between varied MPs and NHS leaders, the offer has nonetheless not been taken up.

Professor Sikora advised MailOnline he’s ‘very upset’ that the UK’s well being bosses have not been extra responsive, given the Health Secretary final month declared a nationwide warfare on cancer.

NHS Test and Trace — which was discovered to have failed on its principal aims to restrict transmission — acquired a £22billion finances, Professor Sikora famous. 

But there appears to be ‘no sums’ for taking motion on combating the cancer disaster, which has been exacerbated by the Covid pandemic. The main oncologist warned that individuals ‘will die’ due to the waits they’re dealing with. 

The NHS mentioned Rutherford’s service are already getting used ‘the place they meet affected person want’. 

It comes as a report by the Health and Social Care Committee yesterday warned UK cancer survival charges may reverse due to a scarcity of ‘severe effort’ to cope with the workforce disaster.   

Professor Karol Sikora, founder of Rutherford Health, sent letters in December to the Department of Health and NHS England offering cancer checks and treatment to patients in England and Wales. Pictured: Rutherford Health cancer centre in Newport, South Wales. The company also has centres in Reading, Liverpool, Newcastle and Taunton

Professor Karol Sikora, founding father of Rutherford Health, despatched letters in December to the Department of Health and NHS England providing cancer checks and remedy to sufferers in England and Wales. Pictured: Rutherford Health cancer centre in Newport, South Wales. The company additionally has centres in Reading, Liverpool, Newcastle and Taunton

Lack of ‘severe effort’ on cancer workforce shortages dangers reversal of survival charges, scathing MP-led report warns 

Cancer survival charges may reverse as a result of a scarcity of ‘severe effort’ to cope with the NHS workforce disaster, a scathing report warned immediately. 

The Health and Social Care Committee mentioned NHS staffing shortfalls are ‘jeopardising’ progress on diagnosing cancer early. 

Cancers are more durable to remedy or deal with when they’re noticed late. 

The committee’s report on cancer companies warned that there isn’t a detailed plan to handle shortages of medical oncologists, marketing consultant pathologists, radiologists and specialist cancer nurses.

And delayed remedies and a reluctance to have signs checked due to the pandemic will imply many lives will now finish ‘prematurely’, they mentioned. 

‘Vital’ cancer surgical procedures have been cancelled throughout the newest wave, suggesting the NHS continues to be unable to entry ‘enough’ Covid-free capability to each safeguard and struggle the backlog, the report added. 

It comes simply over a month after Sajid Javid declared a ‘nationwide warfare on cancer’, in an try to enhance Britain’s survival rate for the illness.

His disease-fighting proposals embrace a collection of ‘walk-in’ MRI screening companies in locations like purchasing centres and soccer grounds to velocity up diagnoses. 

At the time of his pledge, the Health Secretary refused to promise any new money to tackle workforce shortages.   

Rutherford Health despatched its first letter, addressing NHS England and the Department of Health, on December 21.

It mentioned it was ‘in a position to play a extra important half in addressing the worrying nationwide backlog in cancer diagnostics and remedy’. 

According to its web site, Rutherford Health already has offers with some NHS trusts to help cancer sufferers.

The company, which has 5 clinics within the UK, pledged that it may offer a ‘scaled-up, extra environment friendly and cost-effective service’.

It additionally made clear its offer could be on a not-for-profit foundation.   

Under the proposed contract, Rutherford Health would offer cancer analysis and remedy companies to any sufferers referred to it by NHS docs. 

The letter states the partnership would enhance cancer analysis charges, ready instances and cancer outcomes. 

‘All of this with out sufferers needing to attend an NHS web site, thereby averting added strain on present NHS companies,’ the company mentioned.

Rutherford Health mentioned it has the capability to carry out round 75,000 scans per year in England, in addition to 13,500 programs of chemotherapy, 18,000 of radiotherapy and 6,000 of proton beam remedy — a kind of radiotherapy.

The well being service was additionally supplied 15,000 scans and 13,000 programs of remedy in Wales.

Four of the company’s remedy centres are based mostly in England — Reading, Liverpool, Newcastle and Taunton — whereas one is in Newport, Wales.

Rutherford Health’s workforce contains 140 marketing consultant oncologists, 54 radiologists, 15 surgeons and 48 radiographers.

The NHS has beforehand mentioned its chemo and radiotherapy companies had ‘proved very resilient to the pandemic’ and that the pandemic had the most important affect on cancer surgical procedure.

It boasted it has ‘greater than sufficient capability’ for chemotherapy, radiotherapy and proton beam therapies, and has ‘many present suppliers for cancer remedies’.

An NHS spokesperson mentioned: ‘Actually, Rutherford Health’s cancer companies are already getting used the place they meet affected person want as a part of the NHS making good use of the impartial sector all through the pandemic.

‘Despite the pandemic, NHS cancer companies have been prioritised with file numbers of individuals now getting checked for cancer and employees working extremely laborious to deal with extra sufferers in within the final three months than in the identical interval earlier than the pandemic – so when you have any worrying signs, please come ahead for care.’

NHS contracts with England’s non-public hospitals — which value £400million a month throughout the pandemic — got here beneath fireplace for not offering worth for money. 

A thinktank discovered both zero or one contaminated affected person was handled at these hospitals on 60 per cent of days within the first year of the pandemic. 

The impartial sector criticised the well being service for failing to make the most of its willingness to help. Yet insiders final winter accused the non-public sector of ‘taking the p*** and strolling off with the money’.

Professor Sikora advised MailOnline he wrote the letter 4 months in the past and has since been ‘up and down the system’. 

He mentioned the company’s providing would enhance NHS capability, which is ‘simply what the well being service wants’.

Health bosses ‘have been ‘ however ‘no choices have been made’, Professor Sikora mentioned.

‘I’m very upset there has not been extra take-up by NHS bosses,’ he mentioned.

Cancer survival rates could go into reverse because of a lack of 'serious effort' to deal with the NHS workforce, a scathing MP report warned today. NHS Digital data released last Thursday shows survival rates for cancer have been increasing in England significantly from 2004 to 2019. The average one-year survival for all cancers jumped from 64.4 per cent to 74.6 per cent within that 15-year time frame

Cancer survival charges may backtrack due to a scarcity of ‘severe effort’ to cope with the NHS workforce, a scathing MP report warned immediately. NHS Digital knowledge launched final Thursday reveals survival charges for cancer have been growing in England considerably from 2004 to 2019. The common one-year survival for all cancers jumped from 64.4 per cent to 74.6 per cent inside that 15-year time-frame 

The performance of the NHS's current cancer referral targets have declined in the past decade with the number of cancer patients who received urgent treatment within two months falling to 67 per cent last year, the target is 85 per cent

 The efficiency of the NHS’s present cancer referral targets have declined previously decade with the variety of cancer sufferers who acquired pressing remedy inside two months falling to 67 per cent final year, the goal is 85 per cent 

Government is making insufficient progress to enhance cancer survival charges, damning report warns 

Britain is making ‘insufficient’ progress in direction of its struggle to enhance cancer companies, a damning report by MPs concluded. 

Experts advising the Health and Social Care Committee examined pledges that the Government had made to enhance cancer outcomes for sufferers.

They dominated the Government is failing to meet its targets to enhance the NHS workforce, velocity up diagnoses and provides all sufferers entry to personalised care.

Staffing points have been underpinning a scarcity of progress in direction of the very important targets, which embrace diagnosing sufferers who have been referred inside 28 days.  

Professor Dame Jane Dacre, chair of the professional panel and ex-president of the Royal College of Physicians, mentioned cancer companies are ‘dealing with overwhelming strain’.

There is not any time to wait  as a result of ‘any delay has an affect on folks’s likelihood of survival’, Professor Sikora warned.

Experts have estimated between 50,000 and 100,000 folks will die due to delays to cancer companies all through the pandemic.

‘To me as a cancer specialist, what’s disappointing is that persons are saying it is going to be 2024 to 2025 earlier than care returns to regular ranges.

‘What goes to occur to folks between at times who have cancer?’ 

An NHS spokesperson mentioned: ‘Actually, Rutherford Health’s cancer companies are already getting used the place they meet affected person want as a part of the NHS making good use of the impartial sector all through the pandemic.

‘Despite the pandemic, NHS cancer companies have been prioritised with file numbers of individuals now getting checked for cancer and employees working extremely laborious to deal with extra sufferers in within the final three months than in the identical interval earlier than the pandemic – so when you have any worrying signs, please come ahead for care.’ 

Cancer survival charges have been rising in England between 2004 and 2019, the newest date NHS Digital figures can be found for.

The common one-year survival for all cancers jumped from 64.4 per cent to 74.6 per cent inside that 15-year time-frame. 

Five-year survival went from 46.8 per cent in 2004 to 55.3 per cent in 2015.

But an MP-led report launched yesterday says these constant will increase may reverse course due to the disaster in staffing.

Written by the Health and Social Care Committee, it estimated the NHS is at the moment wanting 189 medical oncologists, 390 marketing consultant pathologists and 1,939 radiologists, and shall be wanting 3,371 specialist cancer nurses by 2030.

The report additionally warned lack of ‘severe effort’ to enhance NHS non-Covid capability may additionally contribute to a reversal cancer survival charges. 

Former well being secretary Jeremy Hunt, who chairs the committee mentioned: ‘Earlier cancer analysis is the important thing to enhancing total survival charges.

‘However, progress is being jeopardised by employees shortages which threaten each analysis and remedy.

‘We don’t imagine that the NHS is on observe to meet the Government’s goal on early cancer analysis by 2028.’

The Government goals to diagnose 75 per cent of all cancers at stage one or two by 2028. 

Mr Hunt added: ‘We are additional involved on the damaging and extended affect of the pandemic on cancer companies with an actual danger that positive aspects made in cancer survival will backtrack.’

Despite NHS efforts to defend cancer companies throughout Covid, 36,000 fewer folks in England started remedy in contrast to earlier years, the report states

And 3million fewer folks within the UK have been invited for screening between March and September 2020. And 4.6million fewer key diagnostic checks have been carried out, the report added.

Meanwhile, cancer analysis and remedy instances in England have reached all-time lows.

Back to top button